| 000 | 01074 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513215846.0 | ||
| 264 | 0 | _c20000829 | |
| 008 | 200008s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(05)73966-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBenson, J R | |
| 245 | 0 | 0 |
_aTrends in breast cancer incidence, survival, and mortality. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cAug 2000 |
||
| 300 |
_a591; author reply 593 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aEngland _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTamoxifen _xtherapeutic use |
| 650 | 0 | 4 |
_aWales _xepidemiology |
| 700 | 1 | _aPurushotham, A | |
| 773 | 0 |
_tLancet (London, England) _gvol. 356 _gno. 9229 _gp. 591; author reply 593 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(05)73966-0 _zAvailable from publisher's website |
| 999 |
_c10898944 _d10898944 |
||